Back
EHRA Premium Access

Sleep apnea is associated with stroke in young patients with or without atrial fibrillation:A population study of >2 million individuals.

Session: ePosters Day 3
Topic: Stroke in Atrial Fibrillation
Speaker: Doctor B. Deb (East Palo Alto, US)
Event: EHRA 2022

Congress Session

0

About the speaker

Doctor Brototo Deb

CARDIOVASCULAR MEDICINE AND CARDIAC ARRHYTHMIAS AN INCORPORATED MEDICAL GROUP, East Palo Alto (United States of America)
0 follower

94 more presentations in this session

Advanced vascular aging in patients with paroxysmal atrial fibrillation - Data from RACE V

Speaker: Doctor V. Weberndoerfer (Maastricht, NL)

Access
Abstract
Slides
0
Thumbnail

The features of atrial fibrillation occurrence in patients who have undergone COVID-19

Speaker: Professor S. Grigoryan (Yerevan, AM)

Access
Abstract
Slides
0
Thumbnail

Gender gap in study inclusion: Insights from the STAR-FIB cohort study

Speaker: Associate Professor H. Tanner (Bern, CH)

Access
Abstract
Slides
0
Thumbnail

Supraventricular arrhythmias in MINOCA patients

Speaker: Doctor H. Santos (Barreiro, PT)

Access
Abstract
Slides
0
Thumbnail

Neurophysiological status of patients with non-valvular atrial fibrillation

Speaker: Associate Professor E. Shorikov (Chernivtsi, UA)

Access
Abstract
Slides
0
Thumbnail

Access the full session

ePosters Day 3

Speakers: Doctor B. Deb, Doctor V. Weberndoerfer, Professor S. Grigoryan, Associate Professor H. Tanner, Doctor H. Santos...
Access
0
Thumbnail

About the event

Image

EHRA 2022

3 April - 5 April 2022

Sessions Presentations

Congress
logo Image

Related content

EHRA Premium Access

Impact of high-power and very high-power short-duration radiofrequency ablation on procedure characteristics and first-pass isolation during pulmonary vein isolation

5 April 2022

EHRA Premium Access

Atrial high-rate episodes in patients with devices without a history of atrial fibrillation

3 April 2022

EHRA Premium Access

Pulsed field ablation of atrial fibrillation: recurrence rate after first pulmonary vein isolation and first insights into durability at redo procedures

3 April 2022

This platform is supported by

logo Novo Nordisk